| Zheng, Yan sheng |
NCT05397587: An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell) |
|
|
| Not yet recruiting | 4 | 474 | RoW | Experimental Vaccine, Enterovirus Type 71 Vaccine（Vero Cell）, Inactivated, Control Vaccine, Enterovirus Type 71 Vaccine, Inactivated（Human Diploid Cell） | Sinovac Biotech Co., Ltd | Hand, Foot and Mouth Disease | 07/25 | 10/25 | | |
NCT04689165: A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine |
|
|
| Recruiting | 3 | 1280 | RoW | Experimental Group A meningococcal polysaccharide vaccine, Control Group A meningococcal polysaccharide vaccine | Wei Cun, Yunnan Center for Disease Control and Prevention | Meningitis, Meningococcal | 05/21 | 12/21 | | |
NCT04689191: A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine |
|
|
| Recruiting | 3 | 1280 | RoW | Experimental Group A and C meningococcal polysaccharide vaccine, Control Group A and C meningococcal polysaccharide vaccine | Wei Cun, Yunnan Center for Disease Control and Prevention | Meningitis, Meningococcal | 05/21 | 12/21 | | |
NCT05164731: Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above |
|
|
| Recruiting | 3 | 880 | RoW | SARS-CoV-2 Vaccine, Inactivated (Vero Cell) | Chinese Academy of Medical Sciences, Yunnan Center for Disease Control and Prevention | SARS-CoV2 Infection | 08/22 | 10/22 | | |
NCT05163652: Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) Based on Different COVID-19 Inactivated Vaccine in Adults Aged 18 Years and Above |
|
|
| Recruiting | 3 | 432 | RoW | SARS-CoV-2 Vaccine, Inactivated (Vero Cell) | Chinese Academy of Medical Sciences, Yunnan Center for Disease Control and Prevention | SARS-CoV-2 Infection | 08/22 | 10/22 | | |
NCT04280822: Neo-adjuvant Immunochemotheray Versus Neo-adjuvant Chemotherapy for Resectable Esophageal Carcinoma |
|
|
| Recruiting | 3 | 400 | RoW | Neoadjuvant immunochemotherapy | Henan Cancer Hospital | Esophageal Cancer, Surgery, Neoadjuvant Treatment, Survival | 12/23 | 03/28 | | |
NCT06041061: A Study to Evaluate the Efficacy, Safety, and Immunogenicity of SCT1000 in Healthy Women Aged 18-45 Years |
|
|
| Active, not recruiting | 3 | 18000 | RoW | Recombinant 14-Valent Human Papillomavirus Vaccine（Insect Cell）, placebo | Sinocelltech Ltd., Guangxi Center for Disease Control and Prevention, Henan Center for Disease Control and Prevention, Sichuan Center for Disease Control and Prevention, Shanxi Center for Disease Control and Prevention, Yunnan Center for Disease Control and Prevention | HPV InfectioN, HPV-Related Carcinoma | 03/24 | 08/28 | | |
| Recruiting | 3 | 189 | RoW | Roflumilast Cream 0.3%, Zoryve, Vehicle cream | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Plaque Psoriasis | 06/25 | 07/25 | | |
NCT06775860: ICP-332 in Subjects with Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 3 | 552 | RoW | ICP-332 Tablets, ICP-332 Placebo Tablets | Beijing InnoCare Pharma Tech Co., Ltd. | Atopic Dermatitis | 11/26 | 12/26 | | |
NCT04848753: Perioperative Toripalimab (JS001) Combined With Neoadjuvant Chemotherapy in Patients With Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma |
|
|
| Active, not recruiting | 3 | 663 | RoW | Toripalimab combined with cisplatin and paclitaxel, Placebo combined with cisplatin and paclitaxel | Shanghai Junshi Bioscience Co., Ltd. | Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma | 05/27 | 05/27 | | |
NCT05911841: A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis |
|
|
| Active, not recruiting | 2 | 236 | Europe, Canada, Japan, US, RoW | LY3454738, Placebo | Eli Lilly and Company | Atopic Dermatitis | 06/25 | 03/26 | | |
| Recruiting | 2 | 100 | RoW | Baritinib | De-zhi Kang, Fujian Medical University, Tianjin Medical University General Hospital | Intracerebral Hemorrhage, Acute Lung Injury(ALI) | 12/25 | 03/26 | | |
| Recruiting | 1 | 140 | RoW | Sinovac PCV13, PREVNAR 13 | Sinovac Research and Development Co., Ltd. | Pneumococcal Infectious Disease | 02/25 | 07/25 | | |
NCT04886193: FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis |
|
|
| Recruiting | N/A | 20 | RoW | FLOT(Docetaxel+oxaliplatin+leucovorin+5-FU), Treprizumab, Tiggio capsule (S-1) | Guangdong Provincial Hospital of Traditional Chinese Medicine, Shanghai Junshi Bioscience Co., Ltd. | Chemotherapy, Gastric Cancer | 05/22 | 05/23 | | |
NCT06670456: Prospective Cohort of Patients With Intracerebral Hemorrhage |
|
|
| Recruiting | N/A | 3000 | RoW | | De-zhi Kang, Fuzhou University, Fujian Medical University, National Institute of Hospital Administration (China) | Stroke, Acute, Intracerebral Hemorrhage | 12/27 | 12/28 | | |
NCT04423354: A Prospective Clinical Study of Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Ⅱ AEG |
|
|
| Recruiting | N/A | 94 | RoW | Transthoracic Single-hole Assisted Laparoscopic Radical Gastrectomy for Siewert Type Ⅱ Adenocarcinoma of Esophagogastric Junction | Guangdong Provincial Hospital of Traditional Chinese Medicine | Esophagogastric Junction Adenocarcinoma, Siewert Type II Adenocarcinoma of Esophagogastric Junction | 02/24 | 03/24 | | |
| Recruiting | N/A | 400 | RoW | Goal-directed EN therapy, Conventional EN therapy | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Esophagus Cancer | 08/26 | 05/31 | | |
| Cun, Wei |
NCT04689165: A Phase III Clinical Trial of the Group A Meningococcal Polysaccharide Vaccine |
|
|
| Recruiting | 3 | 1280 | RoW | Experimental Group A meningococcal polysaccharide vaccine, Control Group A meningococcal polysaccharide vaccine | Wei Cun, Yunnan Center for Disease Control and Prevention | Meningitis, Meningococcal | 05/21 | 12/21 | | |
NCT04689191: A Phase III Clinical Trial of the Group A and C Meningococcal Polysaccharide Vaccine |
|
|
| Recruiting | 3 | 1280 | RoW | Experimental Group A and C meningococcal polysaccharide vaccine, Control Group A and C meningococcal polysaccharide vaccine | Wei Cun, Yunnan Center for Disease Control and Prevention | Meningitis, Meningococcal | 05/21 | 12/21 | | |
| Yan, Zheng |
MKKCT-100-003, NCT06447779: Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older |
|
|
| Active, not recruiting | 3 | 25000 | RoW | Recombinant Zoster Vaccine (CHO Cell), NaCl solution Placebo | MAXVAX Biotechnology Limited Liability Company | Herpes Zoster | 09/25 | 09/27 | | |
NCT06337071: A Study of the ACYW135 Meningococcal Polysaccharide Conjugate Vaccine |
|
|
| Not yet recruiting | 2 | 1200 | RoW | ACYW135 Meningococcal Polysaccharide Conjugate Vaccine, ACYW135 Meningococcal Polysaccharide Vaccine | Aimei Vacin BioPharm (Zhejiang) Co., Ltd. | Meningococcal Meningitis | 06/24 | 06/25 | | |
NCT06421948: Linperlisib Combined With Chidamide in Patients With PTCL |
|
|
| Recruiting | 1/2 | 100 | RoW | Linperlisib and chidamide, cyclophosphamide, doxorubicin/epirubicin, vincristine, and prednisone | Yanyan Liu | Peripheral T-cell Lymphoma | 12/25 | 05/26 | | |
NCT06063057: Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial |
|
|
| Recruiting | 1/2 | 744 | RoW | low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated, medium dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated, high dose Bivalent Enterovirus Vaccine (Vero Cell), Inactivated, Enterovirus type EV71 vaccine (Vero cell), Inactivated | Sinovac Biotech Co., Ltd | Hand, Foot and Mouth Disease, Herpangina | 12/24 | 04/25 | | |
NCT06478381: L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma |
|
|
| Recruiting | 1 | 22 | RoW | L218CAR19 | Henan Cancer Hospital | Relapsed/Refractory B-cell Lymphomas | 12/25 | 06/26 | | |
